PRME
Prime Medicine Inc.
$4.10
-$0.17(-3.98%)
51
Overall
55
Value
60
Tech
39
Quality
Market Cap
$731.07M
Volume
2.18M
52W Range
$1.11 - $6.94
Target Price
$6.46
EPS Estimates Overview
| Current Quarter | $-0.25 | Next Quarter | $-0.25 |
| Current Year | $-1.29 | Next Year | $-0.96 |
| QoQ Growth | +0.0% | YoY Growth | +25.6% |
| 3Y EPS CAGR | +37.3% | Target Price | $6.46 |
| Consensus | Buy | Upside | +57.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRME | $4.10 | -4.0% | 2.18M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |